(S)-2-Amino-3-(3-methoxyphenyl)propionic acid, 95.0%, 5g

tert-Butyl 4-(pyridin-2-yloxy)piperidine-1-carboxylate, 95.0%, 1g

N-(2-Hydroxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 98%, 100mg

H-Sar-NH2.HCL, 95%, 25g

(2-Chlorophenyl)(pyrrolidin-1-yl)methanone, 98%, 1g

(3aR,8aS)-2-(Isoquinolin-1-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 100mg

2-Allyloxybenzaldehyde>96.0%(GC)5g

Manganese(II) chloride monohydrate, min. 99%, pa, 25 kg, plastic packaging.

1,3-Dibenzoyloxybenzene>98.0%(GC)5g

4-(3-((4-Chloro-6-methoxyquinolin-7-yl)oxy)propyl)morpholine, 97%, 100mg

4-(2,4-Difluorophenoxy)piperidine, 97%, 1g

undecanoyl chloride, 97.0%, 5g

GC capillary column ROTI®Cap-5, 30 m, 0.53 mm, 0.50 µm, 1 Piece(s)